300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in United Kingdom (May 2026)

The most active venture capital funds and angel investors investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Parkwalk Advisors
VC Fund
16 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $860k–$33M
Oxford Science Enterprises
VC Fund
12 United Kingdom, United States, The Netherlands Seed, Series A Biotechnology, Health Care, Software $1M–$34M
UK Innovation & Science Seed Fund
VC Fund
12 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $246k–$10M
GM&C Life Sciences Fund
VC Fund
7 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $61k–$903k
24 Haymarket
VC Fund
7 United Kingdom, United States Seed, Series A Health Care, Software, Information Technology $1.2M–$16M
Archangels
VC Fund
7 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $123k–$7M
Jonathan Milner
Angel
7 United Kingdom, United States, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $430k–$50M
Scottish Investment Bank
VC Fund
6 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Information Technology $307k–$7.6M
Development Bank of Wales
VC Fund
6 United Kingdom, Australia, United States Seed, Debt Financing Health Care, Software, Biotechnology $12k–$2.8M
Selvedge Venture
VC Fund
6 United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Life Science $1.1M–$2.5M
Sofinnova Partners
VC Fund
6 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $4.4M–$57M
Angels in MedCity
VC Fund
6 United Kingdom, United States Seed, Angel Health Care, Biotechnology, Medical $614k–$774k
Newable Private Investing
VC Fund
6 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $184k–$3.8M
Scottish Enterprise
VC Fund
5 United Kingdom, United States, Japan Grant, Seed Biotechnology, Software, Health Care $92k–$4.1M
Deepbridge Capital
VC Fund
5 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $143k–$10M
Epidarex Capital
VC Fund
5 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Therapeutics, Health Care $536k–$38M
Dementia Discovery Fund
VC Fund
4 United States, United Kingdom, Israel Seed, Series A Biotechnology, Health Care, Therapeutics $5M–$42M
AlbionVC
VC Fund
4 United Kingdom, United States, France Series A, Seed Software, Health Care, Artificial Intelligence $1.8M–$13M
O2h Ventures
VC Fund
4 United Kingdom, Hungary Seed, Series A, Pre-Seed Biotechnology, Health Care, Pharmaceutical $614k–$6.1M
Nadav Rosenberg
Angel
4 United Kingdom, Israel, Singapore Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Pharmaceutical $2M–$2M
11.2 Capital
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Software, Information Technology, Health Care $1M–$53M
Angels 5K
VC Fund
4 United Kingdom Seed, Angel Biotechnology, Software, Medical $74k–$1.2M
SR One
VC Fund
4 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.7M–$85M
Mercia Fund Managers
VC Fund
4 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $184k–$21M
Formic Ventures
VC Fund
4 United States, United Kingdom, Hong Kong Seed, Series A Biotechnology, Health Care, Artificial Intelligence $1.3M–$5M
Playfair Capital
VC Fund
4 United Kingdom, United States, Israel Seed, Series A Software, Artificial Intelligence, E-Commerce $815k–$13M
Oxford Capital
VC Fund
4 United Kingdom, United States, France Seed, Series A Software, Mobile, Health Care $1.6M–$13M
Verve Ventures
VC Fund
4 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $911k–$18M
Bioeconomy Capital
VC Fund
3 United States, United Kingdom Series A, Series B, Seed Biotechnology, Life Science, Genetics $1.8M–$42M
Ahren Innovation Capital
VC Fund
3 United Kingdom, United States, Israel Series A, Seed, Series B Artificial Intelligence, Biotechnology, Machine Learning $2.6M–$211M
Octopus Ventures
VC Fund
3 United Kingdom, United States, Germany Series A, Seed, Series B Software, Health Care, FinTech $1.2M–$45M
Kindred Capital
VC Fund
3 United Kingdom, Israel, Germany Seed, Series A, Series B Software, Biotechnology, Information Technology $557k–$30M
Techstart Ventures
VC Fund
3 United Kingdom, Ireland Seed, Pre-Seed Software, Health Care, Information Technology $86k–$2.5M
Syncona Partners LLP
VC Fund
3 United Kingdom, United States, Switzerland Series A, Series B, Series C Biotechnology, Therapeutics, Medical $17M–$123M
Maven Capital Partners
VC Fund
3 United Kingdom, United States, Germany Series A, Seed Software, Information Technology, SaaS $492k–$12M
APEX Ventures
VC Fund
3 Germany, Austria, United Kingdom Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $643k–$16M
Fifty Years
VC Fund
3 United States, Germany, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $1.3M–$80M
Wren Capital
VC Fund
3 United Kingdom Seed, Series A Biotechnology, Health Care, Software $1.5M–$19M
Ada Ventures
VC Fund
3 United Kingdom, Ireland Seed, Pre-Seed, Series A Software, Marketplace, Health Care $614k–$4.8M
Amadeus Capital Partners
VC Fund
3 United Kingdom, United States, Spain Seed, Series B, Series A Software, Artificial Intelligence, Machine Learning $800k–$43M
Martlet Capital
VC Fund
3 United Kingdom, United States Seed, Series A, Pre-Seed Software, Health Care, Biotechnology $184k–$5.7M
Future Planet Capital
VC Fund
3 United Kingdom, United States Convertible Note, Seed Biotechnology, Health Care, Software $614k–$4.4M
R42 Group
VC Fund
3 United Kingdom, United States, Austria Seed, Pre-Seed, Series A Biotechnology, Health Care, Information Technology $429k–$15M
Antler
VC Fund
3 Singapore, United Kingdom, Australia Pre-Seed, Seed, Series A Software, Information Technology, SaaS $100k–$29M
Delin Ventures
VC Fund
3 United Kingdom, Hungary, United States Seed, Series A, Series B Software, Information Technology, Biotechnology $1.5M–$30M
IP Group
VC Fund
3 United Kingdom, United States, Australia Seed, Series A, Series B Health Care, Biotechnology, Therapeutics $369k–$61M
IQ Capital
VC Fund
3 United Kingdom, United States, The Netherlands Seed, Series A Software, Machine Learning, Artificial Intelligence $1.2M–$16M
Stefano Bernardi
Angel
3 Italy, France, Norway Seed, Pre-Seed Software, Biotechnology, Cryptocurrency $2M–$2M
Acequia Capital (AceCap)
VC Fund
3 United States, United Kingdom, France Seed, Series A, Pre-Seed Software, Information Technology, Artificial Intelligence $500k–$19M
Calculus Capital
VC Fund
3 United Kingdom, United States, Ireland Series A, Post-IPO Equity Biotechnology, Software, Health Care $2.9M–$9M
Access all 417 investors in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 16 investments in United Kingdom Life Science startups, 12 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 211
  • Round size: Seed $860k–$3.7M; Series A $1.5M–$12M; Series B $1.8M–$33M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 12 investments in United Kingdom Life Science startups, 15 in the past 12 months

Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 123
  • Round size: Seed $1M–$6.8M; Series A $3.7M–$34M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
  • AlveoGene — Welcome to AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy More information
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 12 investments in United Kingdom Life Science startups, 13 in the past 12 months

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 96
  • Round size: Seed $246k–$2.9M; Series A $2.7M–$10M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
  • Pencil Biosciences — Next Generation Genome Editing Tool
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 7 investments in United Kingdom Life Science startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 32
  • Round size: Seed $61k–$903k
  • Lead/follow: 69% lead, 31% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups, 6 in the past 12 months

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 95
  • Round size: Seed $1.2M–$3.7M; Series A $1.5M–$16M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • myGwork — The global recruitment & networking hub for LGBTQ+ professionals. Find jobs in lesbian, gay, bisexual and transgender friendly organisations. Grow your LGBTQ+ professional network. Read the latest LGBTQ+ professional news.
  • Previsico — Previsico is a spinOut company from Loughborough University specialising in modelling flooding in real-time, using weather predictions to make street-level flood nowcasts and forecasts. The company's mission is to be the leading global provider of cutting-edge flood prediction that saves lives and livelihoods.Its FloodMap Live producesround the clock street-level flood risk predictions and analytics. Uniquely, these are continuously modelled and updated using a combination of different weather forecasts. This allows the company to map the likelihood of short and long-term surface water events in real-time to the street level.
  • Huq Industries — The leading monitoring platform for footfall, dwell, catchment and traffic flows valued by government, retail and real-estate. Used by 50+ councils!
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 7 investments in United Kingdom Life Science startups, 6 in the past 12 months

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $123k–$2.7M; Series A $1.5M–$7M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 7 investments in United Kingdom Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 44
  • Round size: Seed $430k–$10M; Series A $1.8M–$18M; Series B $1.8M–$50M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 6 investments in United Kingdom Life Science startups

Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 195
  • Round size: Seed $307k–$2.5M; Series A $1.5M–$7.6M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 6 investments in United Kingdom Life Science startups, 11 in the past 12 months

Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 149
  • Round size: Seed $307k–$1.8M; Debt Financing $12k–$2.8M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Stratigens — Talent intelligence software| external people analytics | Diversity, location planning and skills data to inform strategy | Data based decision making
  • 2B Enterprising — 2B Enterprising offers an enterprise education program for primary schools that aims to inspire next generation and foster an entrepreneurial mindset.
Show all investments...

Selvedge Venture
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 11
  • Round size: Seed $1.4M–$1.5M; Pre-Seed $1.1M–$2.5M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 6 investments in United Kingdom Life Science startups, 21 in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $614k–$774k
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Atelerix — The Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
  • DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $184k–$2.9M; Series A $1.2M–$3.8M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 5 investments in United Kingdom Life Science startups, 24 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 193
  • Round size: Seed $197k–$2.9M; Grant $92k–$4.1M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • Rapscallion Soda — Award Winning, Fresh Fruit, Low Calorie Soft Drinks, Handmade in Scotland. Fresh batches made weekly. Free UK Mainland Delivery. International Shipping. Ginga Ninja | Burnt Lemon | Dry Lime | Scottish Rhubarb Soda | Scottish Strawberry Soda | Cranachan Soda | Blueberry Soda Love soda. Hate hangovers. Drink local.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 5 investments in United Kingdom Life Science startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 77
  • Round size: Seed $143k–$2.1M; Series A $1.8M–$10M
  • Lead/follow: 78% lead, 22% follow
  • Last fund: Likely still investing — raised $1.2M in 2022

Portfolio highlights

  • Circada — Innovative Circadian lighting reconnects the body clock with nature
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 5 investments in United Kingdom Life Science startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 39
  • Round size: Seed $536k–$8M; Series A $2M–$24M; Series B $2.4M–$38M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Transine Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

Dementia Discovery Fund
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 36
  • Round size: Seed $5.5M–$15M; Series A $5M–$42M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups, 9 in the past 12 months

AlbionVC supports visionary founders with long-term capital and scale-up expertise, and manages c. $1 billion of venture funds, invested in 50+ companies. AlbionVC is the technology investment arm of Albion Capital Group LLP. The technology team invest from seed through to Series B in high growth companies, predominantly in the UK. The team has a focus on B2B software and technology enabled services. AlbionVC %

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 119
  • Round size: Seed $1.8M–$13M; Series A $3.2M–$12M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • tem. — In a few simple steps we can manage your renewable energy needs forever.
  • Ramp Growth — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
Show all investments...

O2h Ventures
VC Fund · 4 investments in United Kingdom Life Science startups

Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 23
  • Round size: Seed $614k–$3.2M; Pre-Seed $1.7M–$2.5M; Series A $1.8M–$6.1M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Pharmaceutical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Israel, Singapore

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
11.2 Capital
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $1M–$4.6M; Series A $7.3M–$20M; Series B $40M–$53M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • Hubble Network — a Satellite network connecting billions of bluetooth devices. GLOBALLY.
  • Orbital Sidekick — Orbital Sidekick utilizes hyperspectral technology - capturing hundreds of narrow contiguous spectral bands, from visible light through infrared. The company develops a space-based infrastructure of hyperspectral sensors to provide monitoring services to the energy sector.Orbital Sidekick was founded in 2016 and is headquartered in San Francisco,California, United States.
Show all investments...

Angels 5K
VC Fund · Winchester, Hampshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $74k–$1.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
  • Novastone Media Ltd. — With its unique asymmetric technology, novastone puts you directly where your clients want to talk to you.
  • Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 4 investments in United Kingdom Life Science startups, 8 in the past 12 months

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 154
  • Round size: Series A $3.7M–$40M; Series B $15M–$85M; Series C $27M–$57M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • Avalyn Pharma — This does NOT display on the home page
  • Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 4 investments in United Kingdom Life Science startups, 8 in the past 12 months

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 119
  • Round size: Seed $184k–$1.8M; Series A $1.2M–$21M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
  • Centuro Global — Centuro Global helps you go global.We help startups, scaleups & corporates enter new markets around the world. All your international expansion needs are serviced from one platform, whether you need legal support, tax & accounting, HR, opening a bank account or finding office space, we can assist across the board.Our innovativeplatform, Centuro Connect, contains blueprints on how to do business in over 150 countries, provides live chat advice, and access to local experts around the world. Instead of losing time undertaking Google searches for relevant information and identifying trusted, cost-effective service providers, find all your solutions through Centuro Connect.Come to us for services including; Legal, Immigration, Intellectual Property, Scaling & Expansion, New Market Entry, Tax & Accounting and much more.Receive advice, find service providers, investors and like minded individuals, and seamlessly grow your business.Book a free consultation with us: www.centuroglobal.com
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$5M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Turn.bio — Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered.​Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation ofcellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
  • cheMastery — Laboratory Automation
  • Sampling Human — On a mission to elevate societal health with living diagnostics that detect disease and measure effects of lifestyle choices at the single cell level.
Show all investments...

Playfair Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups, 10 in the past 12 months

Playfair Capital is an early-stage fund that commits to companies early and with conviction. Based in London, Playfair combines the best aspects of angel investing with a focused fund, to invest in truly ambitious founders, wherever they are in the world. Playfair takes a sector-agnostic approach and investments span deep tech, SaaS, marketplacesand B2B companies. We’ve backed the founders of more than 60 companies including Mapillary (acq. Facebook), CryptoFacilities (acq. Kraken), Omnipresent, Orca AI, Ravelin, sprout.ai, Thought Machine, Trouva and Vinehealth.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 107
  • Round size: Seed $815k–$8M; Series A $2M–$13M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • Ascento — Secure, maintain, and inspect outdoor assets by reducing the intervention times and augmenting data capturing capability.
  • Continuum Industries — Continuum Industries is a developer of Optioneer, the leading software for linear infrastructure optioneering.
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Mobile, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 133
  • Round size: Seed $1.6M–$3.6M; Series A $1.6M–$13M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
  • HelloSelf — The UK's Trusted Online Private Clinical Therapy Service
  • Legislate — Legislate is an easy-to-use contract management platform which provides a suite of customisable contracts for businesses and landlords.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 4 investments in United Kingdom Life Science startups, 16 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 200
  • Round size: Seed $911k–$5M; Series A $2.1M–$12M; Series B $4.1M–$18M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Show all investments...

Bioeconomy Capital
VC Fund · Seattle, Washington, United States · 3 investments in United Kingdom Life Science startups

Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution. Based on its startup operational expertise, product development experience, and globally recognized strategic analysis, it has developed a blueprint for building and deploying technological capabilities that will become a criticalinfrastructure of the 21st-century economy.The company's proprietary blueprint is the distillation of the fund managers'​ five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, EdenWorks, and Lumen Biosciences.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Genetics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $1.8M–$3.5M; Series A $2.7M–$12M; Series B $16M–$42M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Arzeda — Arzeda develops enzyme design technology that presents a new way of thinking about biocatalysis. The company was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology.
  • Parse Biosciences — Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Learn more about how you can use the most scalable single cell platform on the market without the need for custom instrumentation.
  • Lumen Bioscience — We are transforming the way drugs are developed and what they cost.
Show all investments...

Ahren Innovation Capital
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

Ahren Innovation Capital is a World Changing Institution. A group of highly diverse, creative and original thinkers, at the cutting edge of their domains.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Machine Learning
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 28
  • Round size: Seed $2.6M–$5M; Series A $16M–$211M; Series B $20M–$30M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $246M in 2018

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • ZOE — ZOE analyzes your unique gut, blood fat and blood sugar responses. So you can take back control of your health & weight
  • Ambi Robotics — AI-powered robotic parcel sorting solutions for shipping, ecommerce and logistics. Automate package handling with robotic sorting systems.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Octopus Ventures
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups, 36 in the past 12 months

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Health Care, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 273
  • Round size: Seed $1.2M–$6.1M; Series A $2.5M–$15M; Series B $5.9M–$45M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Automata — Automata is a deep-tech company that creates products that empower people to automate physical work. The company's product, Eva, is a lightweight and affordable robot arm built for professionals in a production line, in a lab, a home workshop or even in a classroom. People don't need to be technical experts to communicate with robots. Theweb-based software platform can be programmed by anyone, anywhere, any time, from any device, making it easy to reconfigure for a wide range of different tasks.Automata was founded on 2015 and is headquartered in London, England.
  • Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Israel, Germany

Investor stats

  • Total investments: 81
  • Round size: Seed $557k–$8.6M; Series A $7.4M–$30M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • m3ter — We enable software companies to intelligently deploy all usage-based scenarios whether they charge by subscription, consumption, or a hybrid pricing model.
  • Vitaance — Vitaance is a new insurtech start-up in the life insurance industry. We aim to improve people's quality of life through financial, emotional and physical wellbeing, by creating smart, fair and responsible insurance products enabled by technology. We want to democratize access to life insurance and to a healthier lifestyle.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Show all investments...

Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 3 investments in United Kingdom Life Science startups, 13 in the past 12 months

Techstart Ventures is a leading investor of seed capital across Scotland and Northern Ireland. they are a trusted partner to ambitious founders on their journey to success.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland

Investor stats

  • Total investments: 129
  • Round size: Seed $154k–$2.5M; Pre-Seed $86k–$1.5M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Enzai — Enzai's AI governance platform allows you to build and deploy AI with confidence. Measure your progress in AI responsibility, and get actionable steps with our 3-minute maturity assessment.
  • MDD systems — MDDSystems provides high-quality consultancy and design services in Sensor measurement, Data monitoring, and recording, Wireless data transmission, Data analysis, Project Management. ,
  • Continuum Industries — Continuum Industries is a developer of Optioneer, the leading software for linear infrastructure optioneering.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 37
  • Round size: Series A $17M–$110M; Series B $22M–$123M; Series C $40M–$80M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Beacon Therapeutics — Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.
  • Mosaic Therapeutics — Mosaic Therapeutics is reshaping the interface of computational and experimental medicine to power new medicines for patients.
  • SwanBio Therapeutics — SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, genetically defined neurological conditions.
Show all investments...

Maven Capital Partners
VC Fund · Glasgow, Glasgow City, United Kingdom · 3 investments in United Kingdom Life Science startups, 11 in the past 12 months

Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 126
  • Round size: Seed $492k–$5M; Series A $2.5M–$12M
  • Lead/follow: 72% lead, 28% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • MarraBio — MarraBio Ltd. is a spin out company from Newcastle University using engineered bacterial protein polymers to provide bioactivity to cells at the industrial scale in the cultivated meat sector and beyond.
  • Power Roll — Power Roll has reinvented solar to generate energy anywhere and everywhere, using any surface.
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 3 investments in United Kingdom Life Science startups

APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Austria, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Seed $643k–$5.9M; Pre-Seed $643k–$1.7M; Series A $6M–$16M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
  • Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
  • Refined Laser Systems — Refined Laser Systems is a dynamic biophotonics company.It specialises in creating innovative laser systems for SRS-microscopy and quantum technology.
Show all investments...

Fifty Years
VC Fund · San Francisco, California, United States · 3 investments in United Kingdom Life Science startups, 11 in the past 12 months

WE BACK HEROES using technology to solve the world's biggest problems

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 139
  • Round size: Seed $1.3M–$11M; Series A $6M–$30M; Series B $8.5M–$80M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
  • Elicit — Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers.
Show all investments...

Wren Capital
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $1.5M–$3M; Series A $2.1M–$19M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
  • Bastion Therapeutics — Bastion Therapeutics - Enhancing Tregs To Restore Balance In Inflammatory Disorders Treg cell therapy for inflammatory disorders and autoimmune diseases.
Show all investments...

Ada Ventures
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups, 8 in the past 12 months

Ada Ventures is a venture capital fund, backed by entrepreneurs and a group of global, mission-aligned investors. The fund invests in overlooked founders and overlooked markets. Ada Ventures is named after Ada Lovelace, the pioneering computer programmer, and mathematician, who was never recognized during the time she lived for what shecontributed to the advancement of technology and science.

Show more...

Investment focus

  • Industry: Software, Marketplace, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Ireland

Investor stats

  • Total investments: 35
  • Round size: Seed $700k–$3.7M; Pre-Seed $614k–$4.8M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Wangie — Connect with qualified mental health practitioners, ready and available round the clock.
  • Gizmo — AI quizzes that help you learn and remember anything
  • Materials Nexus — Accelerating change to net-zero materials
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 3 investments in United Kingdom Life Science startups, 7 in the past 12 months

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series B, Series A
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 197
  • Round size: Seed $800k–$7.5M; Series A $2M–$25M; Series B $6M–$43M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $86M in 2023

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
  • Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Martlet Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 3 investments in United Kingdom Life Science startups

Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. Investing in the future.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 44
  • Round size: Seed $200k–$2.6M; Pre-Seed $184k–$799k; Series A $983k–$5.7M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Convertible Note, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 113
  • Round size: Seed $614k–$4.4M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Captura — Captura mission is globally scalable carbon capture to support a sustainable future for the climate.
  • Regent — We build all-electric, passenger-carrying, wing-in-ground-effect vehicles to service coastal routes with technology available today.
  • Queen of Raw — Queen of Raw is a global marketplace with AI-powered supply chain software to eliminate and monetize textile waste, tracking and analyzing data to keep unused raw materials out of landfills and turn pollution into profit. An integrated dashboard allows its customers to visualize savings to their bottom- and top-lines as well as to the environmentby the actions they take across the Queen of Raw platform. Queen of Raw has helped 400,000+ users save millions of dollars—and more than a billion gallons of water.Queen of Raw is powered by mmx (http://www.materiamx.com/).
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 3 investments in United Kingdom Life Science startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 23
  • Round size: Seed $614k–$4M; Pre-Seed $429k–$2M; Series A $4.2M–$15M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
  • KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
  • WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 3 investments in United Kingdom Life Science startups, 118 in the past 12 months

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Singapore, United Kingdom, Australia

Investor stats

  • Total investments: 363
  • Round size: Seed $510k–$7.5M; Pre-Seed $100k–$1M; Series A $600k–$29M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • FitFlo — FitFlo brings to life the connected gym experience for Operators, Trainers and Members.
  • Mole — Mole is a digital business card and mobile website software. Connect with your clients, promote your business online and much more. Comes with free customised NFC business card.
  • Optacloud — Fostering a global AI powered ecosystem to achieve 100% cloud efficacy-> effortlessly, economically and eco-consciously. Dev tools stack for automating the entire development lifecycle of cloud apps across- Build, Deploy & Optimize.
Show all investments...

Delin Ventures
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

We invest in early stage technology businesses and, in exceptional cases, will create them from scratch with outstanding partners. We pride ourselves on being open minded and ready to support ideas orthogonal to consensus views.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Hungary, United States

Investor stats

  • Total investments: 27
  • Round size: Seed $1.5M–$8.6M; Series A $5.3M–$30M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
  • Ori Biotech — An innovator in Cell and Gene Therapy with a proprietary, flexible manufacturing platform to enable widespread access to lifesaving treatments
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups, 9 in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 157
  • Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

IQ Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 3 investments in United Kingdom Life Science startups, 12 in the past 12 months

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Show more...

Investment focus

  • Industry: Software, Machine Learning, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 134
  • Round size: Seed $1.2M–$6.1M; Series A $4.3M–$16M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • QuadSAT — QuadSAT provides antenna and RF measurements with state-of-the-art equipment, including a drone platform with payload and custom software.
  • Signaloid — Signaloid provides efficient computing hardware and software technologies to quantify, transmit, and track data uncertainty in computations.
  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in United Kingdom Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Cryptocurrency
  • Stage:Seed, Pre-Seed
  • Geography: Italy, France, Norway

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Show all investments...

Acequia Capital (AceCap)
VC Fund · Seattle, Washington, United States · 3 investments in United Kingdom Life Science startups, 29 in the past 12 months

We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 188
  • Round size: Seed $964k–$5M; Pre-Seed $500k–$3.2M; Series A $3.3M–$19M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
  • Windup Minds — Windup Minds is a game studio focused on creating VR and MR virtual pet experiences. The company runs a gaming studio that aims to bring virtual pet games to market.
  • Harbinger — Founded by veterans of Canoo and Faraday Future, Harbinger is an automotive company that develops EV platforms optimized for medium-duty trucks and delivery vans.
Show all investments...

Calculus Capital
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Post-IPO Equity
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 59
  • Round size: Series A $3.1M–$6.5M; Post-IPO Equity $2.9M–$9M
  • Lead/follow: 68% lead, 32% follow

Portfolio highlights

  • Wazoku — Wazoku - Where Innovation Works Wazoku
  • Arctic Shores — Unearth meaningful, job-relevant insights through our candidate assessments. A new type of behaviour based assessment that's powered by neuroscience.
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

Life Science Investor funding in United Kingdom at a glance

Stats across 327 deals from 417 investors.

417
investors
in United Kingdom Life Science startups
327
deals
in United Kingdom Life Science startups
$2.7M
median round
in United Kingdom Life Science startups
41%
lead investors
lead at least one round
31%
Seed
most common funding stage
89/11
VC / Angel
share of investor count

Access all 417 investors in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 417 investors investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists